Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
paradigm 2: Nonacog beta pegol in Hemophilia B
NCT01333111Phase 3Completed
- Sponsor
- Novo Nordisk
- Start
- Apr 2011
- Primary completion
- Mar 2013
- Modality
- Polymer-based Nanoparticles, Recombinant Proteins and Enzymes
- Countries
- 15
01
Overview
A Phase 3 trial of nonacog beta pegol in hemophilia B (HB), sponsored by Novo Nordisk. Started Apr 2011; status: completed.
02
Drugs
nonacog beta pegol
03
Conditions
hemophilia B (HB)
Beyond the preview
Go deeper on NCT01333111.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01333111.